Information Provided By: 
Fly News Breaks for October 28, 2015
MDSO
Oct 28, 2015 | 06:38 EDT
As previously reported, Topeka upgraded Medidata to Buy from Hold and lowered its price target to $50 from $53 on shares. Analyst Eugene Mannheimer is impressed with Medidata's solid cash generation, customer, billings, and pipeline growth and recommends using recent weakness as a buying opportunity.
News For MDSO From the Last 2 Days
There are no results for your query MDSO
